Page last updated: 2024-11-05

tolperisone and Parkinson Disease

tolperisone has been researched along with Parkinson Disease in 2 studies

Tolperisone: A centrally acting muscle relaxant that has been used for the symptomatic treatment of spasticity and muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1211)

Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DOBI, S1
BLONDEL, F1
COULEON, M1
COULEON, H1
ANNE, L1
CLERC, G1
COULOMBIER, J1

Other Studies

2 other studies available for tolperisone and Parkinson Disease

ArticleYear
[Mydocalm and muscle tone].
    Therapia Hungarica (English edition), 1961, Volume: 9

    Topics: Humans; Multiple Sclerosis; Muscle Spasticity; Muscle Tonus; Paralysis; Parasympatholytics; Parkinso

1961
[MYDOCALM TREATMENT OF PSEUDO-PARKINSON DISORDERS FOLLOWING THE ADMINISTRATION OF NEUROLEPTIC AGENTS].
    Annales medico-psychologiques, 1964, Volume: 122

    Topics: Antipsychotic Agents; Drug Therapy; Parasympatholytics; Parkinson Disease; Parkinsonian Disorders; P

1964